Major Drug Interaction

Can You Take Tramadol with Pregabalin?

A plain-English look at the major interaction between Tramadol (Tramal) and Pregabalin (Lyzalon) — what it means, why it happens, and what to talk to your doctor or pharmacist about.

Reviewed by , Registered Pharmacist
Last reviewed: How we research and review
Major severity AllMeds interaction database

Taking Tramadol (Tramal) with Pregabalin (Lyzalon) is a major drug interaction that should be avoided. Respiratory depression, excessive sedation, overdose. Additive CNS depression. Gabapentinoids potentiate opioid-induced respiratory depression even at therapeutic doses.

Not sure about your specific combination? Check it in the Drug Interaction Checker →

Key Takeaways

  • Interaction severity: Major
  • Risk: Respiratory depression, excessive sedation, overdose.
  • Mechanism: Additive CNS depression. Gabapentinoids potentiate opioid-induced respiratory depression even at therapeutic doses.
  • Tramadol: S4 in Australia, low risk
  • Pregabalin: S4 in Australia, moderate risk
  • Claims action: Flag for immediate prescriber review. Document intervention in claim file.

Tramadol vs Pregabalin at a Glance

Property Tramadol Pregabalin
Brand names Tramal, Zydol, Tramedo Lyzalon, Pregabalin Sandoz, APO-Pregabalin
Drug class opioid gabapentinoid
Risk level low moderate
TGA Schedule (AU) S4 S4

Why Is This Combination Dangerous?

Additive CNS depression. Gabapentinoids potentiate opioid-induced respiratory depression even at therapeutic doses.

Clinical risk: Respiratory depression, excessive sedation, overdose.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.

The TGA has issued safety communications about the risk of respiratory depression when gabapentinoids are combined with opioids. WorkSafe Victoria Drugs of Dependence Guidelines require monitoring for this combination.

United Kingdom NICE / MHRA / FPM

The MHRA has issued Drug Safety Updates warning about the risk of respiratory depression and death when gabapentinoids are combined with opioids. NICE CG173 (Neuropathic Pain) recommends gabapentinoids as monotherapy, not in combination with opioids.

United States FDA / CDC / State WC

The FDA has added warnings to gabapentinoid labels about serious breathing difficulties when taken with opioids. The CDC opioid guidelines recommend caution with concurrent CNS depressant use. Some state formularies require prior authorization for this combination.

What Claims Professionals Should Do

  1. Flag immediately as a high-risk prescribing pattern in the claim file
  2. Request urgent prescriber review with documented clinical justification for the combination
  3. Consider an independent medical examination if the prescriber cannot provide adequate justification
  4. Assess work capacity impact as the combination significantly increases sedation and impairment risk
  5. Document all interventions for audit trail and compliance purposes
  6. Check Reasonable and Necessary status for both medications against the compensable injury

Clinical reference

Major Regulator-flagged

A clinical summary of Tramadol and Pregabalin drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.

Severity assessment

Major. The concomitant use of pregabalin and tramadol significantly increases the risk of severe central nervous system (CNS) depression, including life-threatening respiratory depression, coma, and death.

Mechanism (plain English)

Both pregabalin and tramadol affect the central nervous system, but through different pathways. Tramadol is an opioid pain reliever that works by binding to opioid receptors in the brain and spinal cord, reducing pain signals. It also increases the levels of certain brain chemicals like serotonin and norepinephrine. Pregabalin is an anticonvulsant that works by calming overactive nerve cells, which helps reduce nerve pain and seizures. When taken together, their individual sedative effects on the brain and breathing are added together, leading to a much stronger overall effect than either drug alone. This additive effect on CNS depression is primarily pharmacodynamic, meaning they both act on the same body systems to produce similar effects, intensifying the risk of side effects.

Evidence level

Regulator-flagged. Warnings regarding the concomitant use of gabapentinoids (like pregabalin) with opioids (like tramadol) are explicitly stated in product information documents and safety advisories from regulatory bodies such as the Australian Therapeutic Goods Administration (TGA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

Top regulator advisories (cite verbatim or close paraphrase)

  • TGA (Australia): The Australian Product Information for Lyrica (pregabalin) states: "LYRICA poses risks of misuse, abuse and dependence which can lead to overdose and death especially when used concomitantly with opioids and other CNS depressants. Assess the patient’s risk of misuse, abuse or dependence before prescribing and monitor the patient regularly during treatment, particularly amongst patients with current or past misuse, abuse or dependence of opioids and/or benzodiazepines." [3] Similarly, the Australian Product Information for Tramal (tramadol) warns: "Concomitant use of opioids with benzodiazepines, gabapentinoids, antihistamines, tricyclic antidepressants, antipsychotics, cannabis or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Limit dosages and durations to the minimum required; and monitor patients for signs and symptoms of respiratory depression and sedation." [4]
  • MHRA / NICE (UK): The MHRA has issued advisories on improving information supplied with gabapentinoids (pregabalin/gabapentin), benzodiazepines, and Z-drugs, highlighting warnings regarding addiction, dependence, withdrawal, and tolerance. [5] While not specific to the pregabalin-tramadol pair, it underscores the general concern for CNS depressant interactions. Patient.info, a UK-based health information site, explicitly states: "Taking pregabalin and tramadol together can significantly increase the risk of serious side effects. Both medications slow down the central nervous system, which can lead to extreme sleepiness, dizziness, and confusion. Most importantly, this combination can cause dangerous breathing problems (respiratory depression) where your breathing becomes too shallow or slow, which can be life-threatening." [2]
  • FDA / CDC (US): Drugs.com, a widely referenced US-based drug information site, classifies the interaction between tramadol and pregabalin as "Major," stating: "Using narcotic pain or cough medications together with other medications that also cause central nervous system depression such as pregabalin can lead to serious side effects including respiratory distress, coma, and even death." [1]
  • EMA (Europe): No specific pair-specific public advisory found, but the European Medicines Agency (EMA) product information for pregabalin also includes warnings about CNS depressant effects and the risk of respiratory depression, especially when co-administered with other CNS depressants.

Clinical risk factors that elevate the danger

  • Concomitant use of other CNS depressants: Taking other medications that cause drowsiness or slow breathing, such as benzodiazepines, other opioids, alcohol, or certain antidepressants, significantly increases the risk of severe adverse effects. [1, 4]
  • Elderly, frail, or debilitated patients: These individuals may have altered drug metabolism and clearance, making them more susceptible to respiratory depression and other CNS effects. [4]
  • Pre-existing respiratory conditions: Patients with chronic obstructive pulmonary disease (COPD), asthma, or other respiratory impairments are at a higher risk of life-threatening respiratory depression. [4]
  • Renal impairment: Both drugs are primarily eliminated by the kidneys. Impaired kidney function can lead to higher drug levels in the body, increasing the risk of side effects. [3, 4]
  • History of substance abuse: Patients with a personal or family history of drug or alcohol abuse are at increased risk of misuse, abuse, and dependence on both pregabalin and tramadol. [3, 4]
  • High doses or rapid dose escalation: Starting with high doses or increasing doses too quickly can heighten the risk of adverse events. [4]

What a patient should be told

  • Serious risks: Combining pregabalin and tramadol can cause extreme drowsiness, dizziness, confusion, and dangerously slow or shallow breathing, which can be life-threatening. There's also an increased risk of seizures. [2]
  • Do not stop suddenly: If you are taking both medications, do not stop either one suddenly without consulting your doctor or pharmacist, as this can lead to severe withdrawal symptoms or seizures. [3]
  • Warning signs: Be aware of warning signs such as unusual sleepiness, difficulty waking up, very slow or shallow breathing, severe dizziness, or confusion. [2]
  • Discuss alternatives: Talk to your doctor or pharmacist about all other medications you are taking, including over-the-counter drugs, herbal supplements, and alcohol, to ensure this combination is safe for you. They may suggest alternative treatments or adjust your doses. [1, 2]
  • Urgent care triggers: Seek immediate medical help if you experience extreme sleepiness, difficulty waking up, slow or shallow breathing, or any signs of an allergic reaction like swelling of the face or throat. [2, 3]

Top 3 sources (with full citation)

  1. Drugs.com. (Unknown). Pregabalin + Tramadol: Can You Take Them Together? Retrieved from https://www.drugs.com/drug-interactions/pregabalin-with-tramadol-1937-0-2221-0.html
  2. Patient.info. (2026, January 25). Can I take Pregabalin and Tramadol together? Retrieved from https://patient.info/medication-interactions/pregabalin-and-tramadol-interaction
  3. Arrotex Pharmaceuticals Pty Ltd. (Unknown). AUSTRALIAN PRODUCT INFORMATION – LYRICA® (pregabalin) capsule. Retrieved from https://medsinfo.com.au/api/documents/Lyrica_PI?format=pdf

Notes for the reviewing pharmacist

The interaction between pregabalin and tramadol is primarily pharmacodynamic, leading to additive CNS depression. While some pharmacokinetic studies have suggested no significant pharmacokinetic interaction [e.g., Lee et al., 2018, PubMed ID: 30136102], the clinical consensus and regulatory warnings emphasize the heightened risk of respiratory depression and sedation due to their combined CNS depressant effects. It is crucial to counsel patients on the risks of concomitant use, especially with other sedatives or alcohol. Particular attention should be paid to patients with a history of substance abuse, respiratory compromise, or renal impairment. The potential for serotonin syndrome with tramadol, especially if other serotonergic agents are co-administered, should also be considered, although pregabalin itself is not typically associated with this risk. Monitoring for signs of misuse, abuse, and dependence is essential, and gradual withdrawal is recommended if discontinuation is necessary for either drug. The term "gabapentinoids" is increasingly used by regulators to group pregabalin and gabapentin due to similar safety concerns, particularly regarding misuse and CNS depression when combined with opioids.

Sources used in this brief (5)

Check this medication against your full medication list

Check all interactions for Tramadol and Pregabalin across your claimant's full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.